Sun Pharma Secures Bridge Loan for $12 Billion Organon Purchase

Sun Pharmaceutical Industries Ltd. has lined up a short-term loan to help finance its $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the transaction.

At least three banks — Mitsubishi UFJ Financial Group Inc., JPMorgan Chase & Co. and Citigroup Inc. — have committed to provide the funding, though the final size may change as the deal takes shape, the people said, asking not to be identified because the information is private.